Clopidogrel as adjunctive antiplatelet therapy during coronary stenting
Gregory J. Mishkel, MD, FACCa,
Frank V. Aguirre, MD, FACCa,
Robert W. Ligon, MSa,
Krishna J. Rocha-Singh, MD, FACCa,
Charles L. Lucore, MD, FACCa for Prairie Cardiovascular Consultants Ltd
a Prairie Educational and Research Cooperative, Division of Cardiology, Southern Illinois University School of Medicine, Springfield, Illinois, USA
View larger version (15K):
[in a new window]
|
Figure 1 Frequency of use of clopidogrel among interventionalists during the study period, March 1, 1998, through July 31, 1998 (N = 14 interventionalists).
|
|
|
